News
LNTH
63.07
-1.16%
-0.74
Should You Buy Encompass Health (EHC) Ahead of Q1 Earnings?
NASDAQ · 15h ago
Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
NASDAQ · 16h ago
Weekly Report: what happened at LNTH last week (0415-0419)?
Weekly Report · 22h ago
Will Lantheus Holdings (LNTH) Beat Estimates Again in Its Next Earnings Report?
NASDAQ · 3d ago
Lantheus Holdings Price Target Raised to $99.00/Share From $95.00 by B. Riley Securities
Dow Jones · 4d ago
Lantheus Holdings Is Maintained at Buy by B. Riley Securities
Dow Jones · 4d ago
B. Riley Securities Maintains Buy on Lantheus Holdings, Raises Price Target to $99
Benzinga · 4d ago
Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Johnson & Johnson (JNJ) and Lantheus (LNTH)
TipRanks · 5d ago
LANTHEUS HOLDINGS INC <LNTH.O>: B. RILEY RAISES TARGET PRICE TO $99 FROM $95
Reuters · 5d ago
Buy Rating for Lantheus Holdings with Strong Growth and Acquisition Potential
TipRanks · 5d ago
FHLC: Healthcare Dashboard For April
Seeking Alpha · 6d ago
Elevance Health (ELV), CD&R to Unveil Primary Care Offering
NASDAQ · 6d ago
Lantheus Holdings (LNTH) Stock Moves -0.89%: What You Should Know
NASDAQ · 04/15 22:00
BUZZ-Truist bets on a 'beat & raise' Q1 for some med-tech players
Brokerage Truist Securities expects Q1 results beat and forecast raises for medical device makers Boston Scientific Corp BSX.N and Intuitive Surgical. Truist believes medical-technology sector will see rising earnings this quarter. Medical device makers have been benefitting from a resurgence in demand for joint replacements.
Reuters · 04/15 14:54
Weekly Report: what happened at LNTH last week (0408-0412)?
Weekly Report · 04/15 10:13
Buy These 4 Low-Beta Stocks to Counter Market Volatility
NASDAQ · 04/15 09:59
Why HCA Healthcare (HCA) is a Smart Addition to Your Portfolio
NASDAQ · 04/09 18:24
Why You Should Add Ensign Group (ENSG) to Your Portfolio Now
NASDAQ · 04/08 17:56
Weekly Report: what happened at LNTH last week (0401-0405)?
Weekly Report · 04/08 10:16
5 Medical Product Stocks to Buy Amid Industry Challenges
NASDAQ · 04/02 12:35
More
Webull provides a variety of real-time LNTH stock news. You can receive the latest news about Lantheus Holding through multiple platforms. This information may help you make smarter investment decisions.
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, NEUROLITE, Xenon-133, CARDIOLITE, RELISTOR, Automated Bone Scan Index, and others. Its commercial products are used by cardiologists, internal medicine physicians, and others.